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Helicobacter marmotae has been identified in the inflamed livers of Eastern woodchucks
(Marmota monax) infected with woodchuck hepatitis virus (WHV), as well as from the livers of
WHV-negative woodchucks. Because the majority of WHV-positive woodchucks with hepatic
tumours were culture or PCR positive for this helicobacter, and WHV-negative woodchucks with
H. marmotae had hepatitis, the bacterium may have a role in tumour promotion related to chronic
inflammation. In this study, the type strain of H. marmotae was inoculated intraperitoneally into 48
male and female A/J mice, a strain noted to be susceptible to Helicobacter hepaticus-induced
liver tumours. Sixteen mice served as mock-dosed controls. At 6, 12 and 18 months post-
inoculation (p.i.), there were statistically significant (P,0.05) differences in mean inflammation
scores for the caecum and proximal colon between experimentally infected and control mice.
Differences in hepatic inflammation were significant (P,0.05) at 6 and 12 months p.i. between
the two groups but not at the 18 month time point. Two infected male mice had livers with severe
hepatitis, and the liver samples were culture positive for H. marmotae. Serum IgG levels in the
mice dosed with H. marmotae were elevated for the duration of the study. These results
demonstrate that the woodchuck helicobacter can successfully colonize mice and cause
enterohepatic disease. In the future, a mouse-adapted strain of H. marmotae could be selected to
maximize colonization and lesion development. Such a woodchuck helicobacter-infected mouse
model could be used to dissect potential mechanisms of microbial co-carcinogenesis involved in
tumour development in woodchucks with WHV and in humans with hepatitis B virus.
INTRODUCTION
Although the impact that gastric helicobacter species,
particularly Helicobacter pylori, have had on our current
understanding of gastrointestinal disease cannot be over-
estimated, the ability of enterohepatic helicobacters to
cause disease is also being examined. Naturally occurring
enterohepatic species have been found associated with
pathological conditions in humans and animals on
numerous occasions. For example, Helicobacter cinaedi
was isolated from bacteraemic humans and from the liver
of a rhesus macaque with hepatitis and idiopathic colitis
(Cimolai et al., 1987; Fox et al., 2001; Orlicek et al., 1993;
Vandamme et al., 1990). The liver of a puppy with
multifocal hepatitis was colonized with Helicobacter canis,
and the organism was cultured from diarrhoeic faeces of a
child and bacteraemic humans (Burnens et al., 1993; Fox
et al., 1996a). ‘Helicobacter rappini’ (now classified in the
Helicobacter bilis taxon) was recovered from ovine fetuses
with hepatic necrosis, and has been described in association
with gastroenteritis and bacteraemia in humans (Archer
et al., 1988; Kirkbride et al., 1985; Weir et al., 1999). A
novel helicobacter belonging to the H. bilis taxon has been
identified in the livers and colons of hamsters with
hepatobiliary and intestinal disease (Fox et al., 2009).
Similarly, the inflamed livers of mice were shown to be
naturally infected with H. bilis (Fox et al., 1995, 2004).
Aged male A/JCr mice infected with Helicobacter hepaticus
have an increased incidence of hepatomas and hepatocel-
lular carcinomas, whilst infected immunodeficient mice
not only develop chronic hepatitis but also inflammatory
bowel disease and colon cancer (Erdman et al., 2003, 2009;
Fox et al., 1996b; Li et al., 1998; Ward et al., 1996). Other
studies have also involved H. hepaticus inoculation into
helicobacter-free mice, with the result of liver lesions or
inflammatory bowel disease depending on mouse strain
and experimental design (Cahill et al., 1997; Fox et al.,
1996b, c, 2010; Whary et al., 1998).
A novel enterohepatic helicobacter named Helicobacter
marmotae has been detected, by culture and PCR, from the
inflamed livers of Eastern woodchucks (Marmota monax),
some of which were infected with woodchuck hepatitis
Abbreviations: H and E, haematoxylin and eosin; p.i., post-inoculation;
WHV, woodchuck hepatitis virus.
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cats (Fox et al., 2002). For years, the woodchuck–WHV
system has been used as a model of hepatitis B virus
infection in humans (Menne & Cote, 2007; Tennant &
Gerin, 2001). Its popularity is sustained because wood-
chucks with chronic WHV infection develop hepatocellular
carcinomas and hepatitis at a high frequency, with lesions
similar to those in humans with hepatitis B virus. As nine
out of ten WHV-infected woodchucks that had hepatic
tumours and all WHV-negative woodchucks that had
inflamed livers were either culture or PCR positive for H.
marmotae, the question arises as to whether chronic
inflammation associated with the presence of H. marmotae
can act as a tumour promoter. Besides the gastric helico-
bacters H. pylori and Helicobacter mustelae, precedence for
helicobacter involvement in carcinogenesis has been
demonstrated with H. hepaticus in A/J, AxB, B6C3F1,
AB6F1 and B6Af1 mice (Fox & Wang, 2000; Fox et al.,
1997; Garcia et al., 2008; Hailey et al., 1998; Ihrig et al.,
1999; Ward et al., 1994). In the present study, male and
female A/J mice were inoculated with the type strain of H.
marmotae to evaluate features of colonization, concomitant
pathology and serological response. Achieving H. marmo-
tae colonization in mice for future experiments has obvious
advantages over using the original woodchuck host, such as
a shorter generation time and the availability of inbred and
genetically engineered strains.
METHODS
Animals. Thirty-two male and thirty-two female A/J mice of 4–6
weeks of age received from The Jackson Laboratory were helicobacter-
free and free of antibody to specific murine viruses. During the study,
four same-sexed mice per cage were housed in microisolator cages
within an Association for Assessment and Accreditation of Laboratory
Animal Care-accredited facility. All animal manipulations were pre-
approved by the Committee on Animal Care of the Massachusetts
Institute of Technology.
Bacterial inoculation and study design. H. marmotae (ATCC
BAA-546) was grown under microaerobic conditions at 37 uCi n
sterile Brucella broth (Difco Laboratories) containing 5% fetal calf
serum (Summit Biotechnology). After 48 h of incubation on a rotary
shaker, the culture was centrifuged at 9300 g for 20 min at 4 uC.
Phase microscopy and Gram staining were used to assure the purity
of the culture. The bacterial pellet was resuspended in sterile PBS
to a concentration of approximately 10
7 organisms ml
21 based on
spectrophotometric examination. Using a previously published
inoculation strategy, experimental mice (24 males, 24 females)
received 0.2 ml inoculum by intraperitoneal injection, whilst control
mice (8 males, 8 females) were given 0.2 ml sterile PBS (McCathey
et al., 1999; Shomer et al., 2001). One mouse from each cage (total of
two control and six experimental mice of each sex) was necropsied
at 6 and 12 months after dosing; necropsies on the remaining mice
were performed when the study was concluded at 18 months post-
inoculation (p.i.).
Reisolation of H. marmotae from faeces, caeca and livers.
Pooled faeces (three to four pellets) from each cage of mice were
collected at 1, 3, 6 and 9 months p.i. and placed in 500 ml Brucella
broth with 30% glycerol. At necropsy, liver samples were excised
aseptically and the caeca were gently scraped to remove luminal
contents prior to storage in the Brucella broth/glycerol freezer
medium. Faecal and tissue samples were frozen at –70 uC until
further processing. To culture for H. marmotae, the sample material
was homogenized in the freezer medium and the supernatant passed
through a 0.45 mm filter. Filtered aliquots were placed on blood agar
plates containing cefoperazone, vancomycin, and amphotericin B
(CVA medium; Remel). The plates were incubated for up to 2 weeks
in a microaerobic environment at 37 uC.
Analysis of faecal, caecal and hepatic DNA by PCR. Faecal
pellets were also collected from each cage at 1, 3, 6 and 9 months p.i.
to assess for the presence of helicobacter DNA. Three to four faecal
pellets were homogenized in 1 ml PBS and DNA was extracted from
the supernatant solution following the kit manufacturer’s instructions
(QIAamp DNA mini kit and QIAamp DNA blood mini kit; Qiagen).
DNA from caecal and liver tissue was obtained using a High Pure
PCR template preparation kit (Roche Molecular Biochemicals). PCR
was performed using either all-helicobacter primers (C97 and C98) or
primers designed specifically for H. marmotae (Fox et al., 1998, 2002).
An aliquot of the PCR product was electrophoresed through a 6%
Visigel separation matrix (Stratagene) followed by ethidium bromide
staining and visualization.
Histology. Caecal and liver tissues were fixed in 10% neutral
buffered formalin, sectioned at 5 mm and stained with haematoxylin
and eosin (H and E) for histopathological analysis. In a blinded
manner, ileocaecal junction and liver morphology were evaluated by
criteria that included inflammation, hyperplasia and necrosis. Lesions
were scored on a scale of 0–4: 0, none; 1, minimal to mild; 2, mild to
moderate; 3, moderate to severe; 4, diffusely severe. A Warthin–Starry
silver stain was used for visual detection of H. marmotae.
ELISA for anti-H. marmotae IgG in serum. An outer-membrane
antigen preparation of H. marmotae was obtained using methods
previously described for H. hepaticus antigen (Whary et al., 1998). A
Brucella broth culture of the bacteria (see above) was washed in PBS
three times. Following microscopic examination for purity, the
bacterial pellet was resuspended in 4 ml 1% N-octyl-b-glucopyrano-
side for 30 min at room temperature. Ultracentrifugation at 100000 g
for 1 h was used to remove insoluble material. After dialysis against
PBS at 4 uC for 24 h, the supernatant protein concentration was
determined. Serum was collected from each mouse at necropsy and
stored at 220 uC. For serum IgG determination, 96-well plates were
coated with 100 ml H. marmotae outer-membrane antigen prepara-
tion (1 mgm l
21) per well in carbonate buffer (pH 9.6) overnight at
4 uC. Biotinylated goat anti-mouse IgG was used as a secondary
antibody. Incubation with ExtrAvidin peroxidase (Sigma-Aldrich)
was followed by 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)
for colour development. Serum samples were diluted 1:100, and IgG
results were reported as mean A405 values, with all samples run in
duplicate.
Statistical analysis. Mice were grouped by inoculation/colonization
status, time point p.i. and gender. For comparison of control and
experimental groups, a Mann–Whitney non-parametric test was
applied. Serological data were assessed by analysis of variance of the
differences between the groups.
RESULTS
Colonization of H. marmotae in A/J mice
Based on cultures of pooled faeces, five out of six cages
housing inoculated male A/J mice had evidence of
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the cages containing inoculated female mice had positive
faecal cultures (Table 1). However, by 3 months p.i.,
females inoculated with H. marmotae housed in two of the
six cages had positive faecal cultures. For the later time
points at 6 and 9 months p.i. when pooled faeces were
assessed, the same experimental cages of male (five out
of six) and female (two out of six) A/J mice remained
persistently colonized with H. marmotae. Faecal cultures
from the mock-infected mice cages were always negative
for H. marmotae. When faeces collected from cages at 1
month p.i. were examined by PCR, all of the cages
containing male experimental mice (six out of six) were
positive. All other post-dosing PCR results on pooled
faeces concurred with the culture results.
Caecal and liver cultures from control mice were con-
sistently negative for H. marmotae. At 6, 12 and 18 months
p.i. when necropsies were performed (Table 1), the caeca of
experimental male and female mice taken from cages that
had positive pooled faecal cultures were positive for H.
marmotae by culture. There were no positive H. marmotae
caecal cultures from experimental mice that came from
cages where detectable H. marmotae infection was never
established, as demonstrated by negative pooled faecal
cultures and PCR. H. marmotae was cultured from the liver
samples of one experimental male A/J mouse necropsied at
12 months p.i. and one male mouse at 18 months p.i.; these
mice also had positive caecal cultures.
A subset of tissue samples chosen at random was analysed
by PCR using H. marmotae-specific primers. The data (not
shown) confirmed the tissue culture results in that the
caeca and livers of dosed but uninfected experimental mice
were negative for H. marmotae DNA at the three necropsy
time points. Also, of the infected experimental mice, only
the livers from which H. marmotae was cultured were
positive by the PCR method.
Histopathological evaluation
Mice infected with H. marmotae developed typhlocolitis
and hepatitis. Inflammation in the large bowel was most
severe at the caecocolic junction and proximal colon. In
more severely affected animals, the caecocolic inflam-
mation extended midway to the caecal apex and through
the mid-distal colon. Inflammatory cells were composed
primarily of lymphocytes, with fewer plasma cells and
macrophages. Neutrophils comprised a minor percentage
of some inflammatory infiltrates, and rare tissue sections
contained eosinophils. Necrosis and hyperplasia were
not important histological features in the large bowel.
Caecocolic inflammation and oedema were limited to the
lamina propria in most instances, although extension to
the submucosa was prominent in more severe cases
(Fig. 1). Multifocal hepatic inflammation was centred on
portal triads, but occasional foci were random in dis-
tribution (Fig. 2). Inflammatory populations in liver sam-
ples were composed chiefly of mononuclear cells (Fig. 3);
however, more severe cases had evidence of chronic
periportal and random hepatitis with mixtures of mono-
nuclear and polymorphonuclear cells. Bacteria with mor-
phology consistent with H. marmotae were visible in the
Warthin–Starry-stained liver sections of mice with positive
liver cultures (Fig. 4). Infected mice with the most severe
liver lesions exhibited mild to moderate intralesional
hepatocellular apoptosis and/or necrosis with little evid-
ence of hyperplasia. Table 1. Culture and PCR results for A/J mice dosed with
H. marmotae
Experiment Time p.i. (months)




5/6 5/6 5/6 5/6 ND ND
Pooled faeces
PCR*
6/6 5/6 5/6 5/6 ND ND
Caecal cultureD ND ND 5/6 ND 5/6 8/10




0/6 2/6 2/6 2/6 ND ND
Pooled faeces
PCR*
0/6 2/6 2/6 2/6 ND ND
Caecal cultureD ND ND 2/6 ND 2/6 2/7
Liver cultureD ND ND 0/6 ND 0/6 0/7
ND, Not done.
*Number of positive cages/total number of cages sampled.
DNumber of positive mice/total number of mice in group.
Fig. 1. Chronic typhlitis in the caecum of a male A/J mouse
infected with H. marmotae for 12 months. H and E stained. Bar,
250 mm.
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infected mice than in mock-dosed controls (Table 2);
experimental mice that were never colonized by H.
marmotae were not included in the statistical analyses.
Regarding caecal and hepatic inflammation there was no
significant difference attributable to gender, except at the
18 month time point when some control female mice had
developed low-grade hepatitis (median lesion score of 1.5
versus 0.5 for the control male mice at 18 months p.i.)
commonly noted in aged inbred mice. Hence, the data on
caecal/proximal colon and hepatic lesion scores from male
and female mice were combined. At 6, 12 and 18 months
p.i., statistically higher (P,0.05) mean inflammation
scores for the caecum and proximal colon were observed
in the colonized experimental mice compared with the
control mice. Differences in hepatic inflammation were
significant at 6 and 12 months p.i. between the two groups
(P,0.05).
Serum IgG responses to H. marmotae
Mice experimentally dosed with H. marmotae, whether or
not colonization occurred, generated an IgG response that
was statistically different (P,0.05) from the titres of the
mock-inoculated group (Fig. 5). The IgG levels in the
experimental groups did not change appreciably between
the 6 and 18 month p.i. time points.
DISCUSSION
Intraperitoneal inoculation of H. marmotae and sub-
sequent colonization by the bacterium resulted in statisti-
cally significant typhlocolitis in A/J mice at 6, 12 and 18
months p.i. compared with mock-dosed mice, and animals
with positive caecal cultures had more severe inflam-
mation. These results are similar to those reported when a
urease-negative novel Helicobacter sp. was inoculated intra-
peritoneally in A/J mice (Shomer et al., 2001); likewise, H.
hepaticus caused typhlitis in A/J mice when given by oral
gavage (Whary et al., 1998). Findings of lower-bowel
pathology in immunocompetent mice caused by Helico-
bacter species are important for modelling inflammatory
bowel disease in humans. In the present study, significant
hepatitis was also related to H. marmotae infection at 6 and
12 months p.i. Hepatic lesions at 18 months p.i. remained
higher in the experimental mice, but these were not
statistically significant because spontaneous focal, mild
hepatitis had developed in selected control mice, a lesion
Fig. 2. Periportal hepatitis (indicated by arrows) and random
hepatitis in a male A/J mouse infected with H. marmotae for
12 months. H and E stained. Bar, 250 mm.
Fig. 3. Higher magnification view of primarily mononuclear cell
infiltrate in the hepatic portal region. H and E stained. Bar, 125 mm.
Fig. 4. Three spiral argyrophilic H. marmotae bacteria (indicated by
an arrow) in a hepatic canaliculus from a culture-positive liver.
Warthin–Starry stained. Bar, 10 mm.
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1997). Overall, the pathology that developed was inflam-
matory in nature, without the hyperplasia and necrosis that
characterizes infection in mice with H. hepaticus (Fox et al.,
1996c; Ward et al., 1994), except for severely affected
experimental mice with hepatitis.
Another difference not observed in H. hepaticus infection
in A/J mice was that H. marmotae-associated lesions did
not progress dramatically from 6 to 18 months. Pathogenic
mechanisms may be different in these two urease-positive
helicobacters, although H. marmotae, like H. hepaticus,
Helicobacter pullorum, H. bilis, H. cinaedi and Campylo-
bacter jejuni, expresses cytolethal distending toxin, which
causes cell-cycle arrest (Chien et al., 2000). The presence
of the toxin in H. hepaticus and H. cinaedi promotes
helicobacter-associated typhlocolitis in interleukin-10-defi-
cient mice (Shen et al., 2009; Young et al., 2004). Whether
this toxin plays a similar role in A/J mice with H.
marmotae-induced gastrointestinal disease requires further
studies.
Once the mice in a given cage were positive by faecal
culture for H. marmotae, all of the animals in that cage
became persistently colonized as shown by caecal cultures
at necropsy. However, whilst the majority of male A/J mice
(five out of six cages) became infected, only one-third of
the females housed in cages were successfully colonized by
the organism. It also took longer for colonization to be
detected in the female mice, as at 1 month p.i. all of the
cultures and PCR analyses of faeces pooled from female
cages were negative for H. marmotae. In addition, the two
liver samples that were culture positive for H. marmotae,
presumably by intestinal translocation, occurred in male
mice. Sporadic liver colonization, despite persistent colo-
nization of the lower bowel, is also characteristic of H.
hepaticus infection in A/J mice (Fox et al., 1996b). Even
though the overall lesion severity indices were similar in H.
marmotae-colonized male and female mice, the highest
hepatitis scores assigned during the study belonged to the
two male mice that had livers from which the organism was
recovered by culture. Female A/J mice may be able to limit
bacterial colonization more effectively than male mice,
perhaps by immune or hormonal mechanisms. The same
gender bias has also been documented in A/J and AXB
mice infected with H. hepaticus (Fox et al., 1996b; Ihrig
et al., 1999; Ward et al., 1994).
One factor that could have negatively affected infection rate
and lesion severity in A/J mice dosed with H. marmotae is
that the bacterial strain used in this study was obtained
Table 2. Caecal/proximal colon and hepatic lesion scores in H. marmotae-colonized A/J mice and
controls
Scores are given as the median (range).
Time p.i. Control mice* Experimental infected mice
6 months
Caecal/proximal colon scores 0.25 (0–0.5) 2.0 (1.0–2.5)D
Hepatic scores 0 (0) 1.0 (0–2.0)D
No. of mice Two males, two females Five males, two females
12 months
Caecal/proximal lesion scores 0.5 (0.5) 2.5 (2.0–3.0)D
Hepatic scores 0.25 (0–0.5) 1.0 (0.5–3.0)D
No. of mice Two males, two females Five males, two females
18 months
Caecal/proximal lesion scores 1.0 (0.5–1.0) 2.25 (1.5–3.0)D
Hepatic scores 0.5 (0.5–1.5) 1.0 (0–3.5)
No. of mice Three males, two females Eight males, two females
*Mice euthanized early due to health concerns were added into the analysis with data for the closest time point
if cultures and complete necropsies were performed.
DP,0.05 compared with value for control mice (Mann–Whitney test).
Fig. 5. IgG response to H. marmotae in the sera of infected (m), H.
marmotae-inoculated but uninfected (&) and control ($) A/J mice.
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In an earlier report, mice were allowed to self-select human
strains of H. pylori; this resulted in mouse-adapted strains,
e.g. SS1, which could efficiently colonize the stomach and
induce inflammation (Lee et al., 1997). Woodchucks and
mice are both members of the order Rodentiae; however,
they are distinct enough from one another to be placed in
different families, Scuiridae and Muridae, respectively. It is
unknown whether woodchucks infected with H. marmotae
have lower-bowel colonization and concurrent intestinal
inflammation. We have recently cultured H. marmotae
from the intestines of prairie dogs and identified it by PCR
in prairie dog livers (J. G. Fox, unpublished data), thereby
increasing its natural host range. To date, H. marmotae has
not been cultured from wild mice.
At 6, 12 and 18 months p.i., A/J mice of both sexes dosed
intraperitoneally mounted a stable IgG serological immune
response to H. marmotae. Likewise, in an earlier study
designed to examine the immune responses of male A/JCr
mice infected orally with H. hepaticus, essentially un-
changed immunoglobulin levels were measured between 3
and 11 months after infection (Whary et al., 1998). Of
interest in the present study was that serum IgG levels
remained elevated at 18 months p.i. in all of the experi-
mentally dosed mice, even in those where persistent
colonization was not evident. A long-term immunological
response to the bacterial antigens could be a consequence
of the intraperitoneal route by which H. marmotae was
administered. Given that H. marmotae is a Gram-negative
bacterium, low-level shedding of Gram-negative enteric
antigens into the portal circulation could elicit ongoing
anamnestic immune responses to shared H. marmotae
antigens. Similarly, serum IgG levels were high in Swiss
Webster outbred mice dosed intraperitoneally with H.
pylori, even though only a minority (one out of eight) of
the mice was colonized with H. pylori 1 month after
dosing. The serum titres were considerably greater than
antibody titres measured in orally dosed mice (McCathey
et al., 1999). In mice dosed intraperitoneally with an
enteric helicobacter, the organism was not isolated from
various tissues (blood, lung, spleen, liver and kidneys)
30 days p.i., but was cultured from faeces (McCathey et al.,
1999). Based on these earlier findings, we also believe it is
unlikely that H. marmotae colonized extraintestinal tissue,
which could have been responsible for the sustained
immune response in experimentally inoculated, but unin-
fected mice. Although intraperitoneal versus oral admini-
stration of Helicobacter species has been used successfully
in the past (McCathey et al., 1999; Shomer et al., 2001;
Ward et al., 1994), oral gavage of H. marmotae in
subsequent experiments will clarify the immunological
effects of the dosing route used.
A high prevalence of H. marmotae DNA has been
documented in WHV-infected woodchuck livers with
hepatic tumours, and WHV-negative woodchucks with
H. marmotae infection had evidence of comparable hepa-
titis (Fox et al., 2002). Others have also described hepatic
lesions in woodchucks seronegative for WHV (Roth et al.,
1985, 1991), although the H. marmotae status of the
woodchucks was not established. H. marmotae in wood-
chucks may induce chronic inflammation that in turn
promotes neoplastic changes in liver parenchyma. The
present report demonstrates that H. marmotae can suc-
cessfully colonize both the lower bowel and liver of
A/J mice, and cause substantial gastrointestinal disease.
Recently, we reported that H. hepaticus infection promoted
liver tumours in hepatitis C transgenic mice as well as in
mice treated with aflatoxin (Fox et al., 2010). Future
murine studies with a mouse-adapted H. marmotae will be
useful for studying mechanisms of microbially induced co-
carcinogenesis, and by extension the possible carcinogenic
role of Helicobacter spp. in humans infected with hepatitis
B and C viruses.
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